Michael Dent, Dennis Robbins, Geoffrey Ginsburg, Nicola Campbell, Jai Nagarkatti, David Harvey | GenomeWeb

NeoGenomics Chairman Michael Dent has been appointed managing director at the company. Dent will now lead the company’s efforts in developing new clinical lab services and collaborative research projects.

GenoMed has named Dennis Robbins chairman of the company’s newly created business advisory board.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.